We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Dehydroepiandrosterone (DHEA) and Letrozole in Treating Patients With Metastatic Breast Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00516542
Recruitment Status : Terminated (Study was terminated due to lack of accrual)
First Posted : August 15, 2007
Last Update Posted : July 24, 2012
National Cancer Institute (NCI)
Information provided by (Responsible Party):
OHSU Knight Cancer Institute

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Terminated
  Primary Completion Date : July 2009
  Study Completion Date : December 2010